Callan Capital LLC Lowers Stock Position in Check Point Software Technologies Ltd. (NASDAQ:CHKP)

Callan Capital LLC lowered its position in Check Point Software Technologies Ltd. (NASDAQ:CHKP) by 21.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,372 shares of the technology company’s stock after selling 368 shares during the period. Callan Capital LLC’s holdings in Check Point Software Technologies were worth $256,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of Montreal Can raised its holdings in shares of Check Point Software Technologies by 32.2% in the third quarter. Bank of Montreal Can now owns 85,639 shares of the technology company’s stock valued at $16,532,000 after purchasing an additional 20,866 shares during the last quarter. CWA Asset Management Group LLC purchased a new stake in Check Point Software Technologies during the third quarter worth about $1,599,000. MML Investors Services LLC increased its holdings in Check Point Software Technologies by 3.7% during the third quarter. MML Investors Services LLC now owns 103,507 shares of the technology company’s stock worth $19,957,000 after buying an additional 3,655 shares during the last quarter. McHugh Group LLC purchased a new stake in Check Point Software Technologies during the fourth quarter worth about $241,000. Finally, Truist Financial Corp increased its holdings in Check Point Software Technologies by 2.6% during the fourth quarter. Truist Financial Corp now owns 119,504 shares of the technology company’s stock worth $22,311,000 after buying an additional 3,080 shares during the last quarter. Hedge funds and other institutional investors own 98.51% of the company’s stock.

Check Point Software Technologies Trading Down 1.0 %

CHKP stock opened at $216.80 on Monday. The firm has a 50 day moving average of $198.23 and a 200-day moving average of $192.18. Check Point Software Technologies Ltd. has a 12 month low of $145.75 and a 12 month high of $226.02. The firm has a market capitalization of $23.84 billion, a P/E ratio of 29.02, a price-to-earnings-growth ratio of 3.41 and a beta of 0.65.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Stifel Nicolaus raised their price objective on shares of Check Point Software Technologies from $190.00 to $220.00 and gave the stock a “hold” rating in a report on Friday, January 31st. Morgan Stanley raised their price objective on shares of Check Point Software Technologies from $183.00 to $200.00 and gave the stock an “equal weight” rating in a report on Friday, January 31st. Truist Financial restated a “buy” rating and set a $250.00 price objective (up previously from $220.00) on shares of Check Point Software Technologies in a report on Friday, January 31st. Guggenheim restated a “neutral” rating on shares of Check Point Software Technologies in a report on Friday, January 31st. Finally, BMO Capital Markets raised their price objective on shares of Check Point Software Technologies from $215.00 to $245.00 and gave the stock a “market perform” rating in a report on Monday, February 3rd. Nineteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $216.95.

Check Point Software Technologies Company Profile

Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a multilevel security architecture, cloud, network, mobile devices, endpoints information, and IOT solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against fifth generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile.